Second Malignant Neoplasms After Childhood ALL Therapy

计划入组 642 人 · 首次发布于 2011 年 11 月 22 日

Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms

计划入组 36 人 · 首次发布于 2024 年 7 月 17 日

SARS-CoV-2 Safety Study for the Treatment of COVID-19

首次发布于 2024 年 7 月 8 日

Malignant neoplasm of liver Vaccine

Melanoma vaccine (Bavarian Nordic)

small molecule therapeutic (malignant glioma)

Aspira Women's Health

United States

Dizal Pharmaceutical Co., Ltd.

NEOPLAS INNOVATION

United States

FDA Approves Peytant Solutions' AMStent for Malignant Airway Obstructions

Biologic Therapies Show Favorable Cancer Safety Profile in Psoriatic Disease Patients

Second Primary Malignancies Emerge as Clinically Relevant Complication of T-Cell–Engaging Bispecific Antibody Therapy